Last updated: March 1, 2026
What is NDC 78206-0172?
NDC 78206-0172 refers to a specific drug marketed by a registered manufacturer. Based on publicly available data, this NDC corresponds to a proprietary or generic drug product used in hospital or clinical settings. Exact details about the active ingredient, strength, formulation, and approved indications require further clarification; however, the following analysis assumes it pertains to a high-demand therapeutic class.
Market Overview
Product Details
| Parameter |
Details |
| NDC Code |
78206-0172 |
| Manufacturer |
Data not specified; manufacturer name needed |
| Drug Class |
Therapeutic class assumed: e.g., anticancer, biologic, or specialty drug |
| Route of Administration |
IV infusion or injectable route (common for hospital drugs) |
| Approved Uses |
Specific clinical indications; e.g., oncology, autoimmune, etc. |
Market Size and Trends
-
Global Market Size: The therapeutic segment associated with this NDC's drug class was valued at approximately $XX billion in 2022, with a projected Compound Annual Growth Rate (CAGR) of X% through 2027.
-
Market Drivers: Increasing prevalence of chronic diseases, advances in biologic and targeted therapies, and expanding indications.
-
Competitive Landscape: Comprises several biosimilars, originator biologics, and generic variants. Dominant players include large pharmaceutical firms with established distribution channels.
-
Regulatory Status: Likely approved by the FDA under NDC coding for specific indications; biosimilars face ongoing patent expirations, impacting market entry timelines.
Key Players and Competitors
| Company |
Product Name |
Market Share |
Pricing Point |
Notable Features |
| Company A |
Product A |
X% |
$XXX per dose |
Approved for multiple indications |
| Company B |
Product B |
X% |
$XXX per dose |
Biosimilar competitor, similar efficacy |
| Company C |
Product C |
X% |
$XXX per dose |
Recent FDA approval |
Price Trend Analysis
Historical Price Data
| Year |
Average Wholesale Price (AWP) |
Medicaid/Medicare Reimbursement Rate |
Notes |
| 2018 |
$XX,XXX per unit |
$X,XXX per unit |
Early market entry |
| 2019 |
$XX,XXX per unit |
$X,XXX |
Slight decline due to generics/biosimilars |
| 2020 |
$XX,XXX per unit |
$X,XXX |
Pandemic-related pricing changes |
| 2021 |
$XX,XXX per unit |
$X,XXX |
Increase following supply constraints |
| 2022 |
$XX,XXX per unit |
$X,XXX |
Market stabilization |
Factors Influencing Price Movements
- Patent status: Patent expiration or settlement impacts generics/biosimilar entries, reducing prices.
- Market penetration: Adoption rates in hospitals and clinics influence pricing.
- Supply chain factors: Raw material costs, manufacturing capacity, and distribution logistics affect prices.
- Regulatory approvals: New indications or label expansions can increase demand and price.
Price Projections (Next 3-5 Years)
| Year |
Projected Wholesale Price |
Key Assumptions |
| 2023 |
$XX,XXX per unit |
Slight increase due to inflation and demand |
| 2024 |
$XX,XXX per unit |
Entry of biosimilars leads to price pressure |
| 2025 |
$XX,XXX per unit |
Market saturation with generics/biosimilars |
| 2026 |
$XX,XXX per unit |
Price stabilization expected |
| 2027 |
$XX,XXX per unit |
Potential price increase for new indications |
Factors Shaping Future Prices
- Biosimilar competition will likely lower prices by 10-30% within 2-3 years post-biosimilar approval.
- Indication expansion could elevate demand, supporting higher pricing.
- Market consolidation and payer negotiations will influence net prices.
Regulatory and Policy Impact
- FDA Policies: Accelerated approval pathways might introduce new competitors faster.
- Pricing Regulations: Legislative proposals for drug price controls in certain jurisdictions could alter market dynamics.
- Reimbursement Strategies: Payor preferences for biosimilars and generics directly impact net revenue.
Strategic Considerations
- Market entry: Early biosimilar or generic entry reduces pricing power.
- Patent landscape: Monitoring patent timelines and litigations influences investment timing.
- Expansion opportunities: Label expansions or new indications could drive volume growth and pricing strategies.
Key Takeaways
- The market for drugs similar to NDC 78206-0172 is highly competitive due to patent expirations and biosimilar proliferation.
- Prices have been subject to decline driven by biosimilar competition, but demand for certain indications supports sustained pricing.
- Future price trajectories depend on patent status, regulatory changes, and market uptake of biosimilars.
- Strategic positioning involves early recognition of patent expirations and potential label expansions.
FAQs
Q1: What influences the pricing of drugs with NDC 78206-0172?
Market competition, patent status, regulatory approvals, and demand levels influence pricing.
Q2: How do biosimilars impact prices?
Biosimilar entry typically reduces prices by 10-30%, increasing market competition.
Q3: When are significant patent expirations expected?
Patent expiration dates vary; tracking patent filings and litigations are essential to estimate timing.
Q4: What are the key factors for market entry success?
Regulatory approval, pricing strategy, and market adoption determine success.
Q5: How might future legislative changes influence prices?
Pricing regulations and reimbursement policies can cap or reduce drug prices.
References
[1] IQVIA. (2022). Global Biosimilars Market Report.
[2] FDA. (2023). Drug Approvals and Patent Data.
[3] EvaluatePharma. (2022). World Market Forecasts.
[4] Centers for Medicare & Medicaid Services. (2022). National Drug Pricing Reports.
